IL Therapeutics Inc. Launches After Receiving Up To C$3 Million 
10/19/2005 5:11:15 PM

IL Therapeutics Inc., an acute inflammatory disease company, launched operations and signed a letter of intent to commercialize an injectable protein drug treatment for acute respiratory distress syndrome with the University of Saskatchewan's Industry Liaison Office.